Methadone dose ceilings and adverse events.

被引：0
|
作者：
Belendiuk, KA
Preston, KL
Schmittner, J
Schroeder, JR
Epstein, DH
Voskanian, SJ
机构：
[1] NIDA, IRP Treatment Sect, Baltimore, MD USA
[2] NIDA, IRP, Baltimore, MD USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2005.12.203
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P56 / P56
页数：1
相关论文
共 50 条
  • [1] Reporting of adverse events.
    Leape, LL
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (20): : 1633 - 1638
  • [2] Strategy for surveillance of adverse drug events.
    Bright, Roselie A.
    FOOD AND DRUG LAW JOURNAL, 2007, 62 (03) : 605 - 615
  • [3] Physician assessment of causality of adverse events.
    Jara, M.
    Lanes, S.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (11) : S38 - S38
  • [4] Risk factors for outpatient adverse drug events.
    Shah, NR
    Poon, EG
    Seger, AC
    Fiskio, J
    Murray, MD
    Overhage, JM
    Bates, DW
    Gandhi, TK
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 : 207 - 207
  • [5] Race and association between ADT and adverse events.
    Friedrich, Nadine
    Janes, Jessica L.
    Parrish, Joshua
    De Hoedt, Amanda Marie
    Tatonetti, Nicholas
    Freedland, Stephen J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Electronically screening discharge summaries for adverse medical events.
    Murff, HJ
    Forster, AJ
    Peterson, JF
    Fiskio, JM
    Heiman, HL
    Bates, DW
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 : 205 - 205
  • [7] Estimates of medical device-associated adverse events.
    Hefflin, B.
    Gross, T.
    Schroeder, T.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (11) : S171 - S171
  • [8] Psychotropic drugs, structural activity relationship and adverse events.
    Knudsen, JF
    Sokol, GH
    Cantilena, LR
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P65 - P65
  • [9] Data mining clinical records to detect adverse events.
    Coster, TS
    Szarfman, A
    Russell, C
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P1 - P1
  • [10] A systematic approach to improve reporting and analysis of adverse drug events.
    Mostella, JP
    Throgmorton, PK
    Cramer, RL
    PHARMACOTHERAPY, 2005, 25 (03): : 476 - 476
12345